While vepdegestrant outperformed a standard treatment option in a subtype of patients, the benefit on progression-free ...

Biocure Technology Inc ( ($TSE:CURE.X) ) has shared an update. Biocure Technology Inc. has successfully closed its previously announced unit ...

Ailsa Craig and Marek Poszepczynski, portfolio managers at the International Biotechnology Trust, tell MoneyWeek where they’d ...

On Saturday, the Stanford Students in Biodesign and Biopharma (SSB) hosted “Impulse,” among Stanford’s premier biotechnology conferences, bringing together a community of students building ...